Jamjoom Pharmaceuticals Factory Company SJSC

Common Name
Jamjoom Pharmaceuticals Factory
Country
Saudi Arabia
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
N/A
Ticker
4015
Exchange
SAUDI STOCK EXCHANGE
Description
Jamjoom Pharmaceuticals Factory is a prominent player in the pharmaceutical industry based in Saudi Arabia. As a manufacturer, the company's primary function is to develop, produce, and distribute a b...

Jamjoom Pharmaceuticals Factory's GHG Emissions Data Preview

In 2024, Jamjoom Pharmaceuticals Factory completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Jamjoom Pharmaceuticals Factory has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Jamjoom Pharmaceuticals Factory’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Jamjoom Pharmaceuticals Factory’s data sources below and access millions more through our Disclosure Search.

a. Jamjoom Pharmaceuticals Factory's Sustainability Report 2024
a. Jamjoom Pharmaceuticals Factory's Sustainability Report 2024

Insights into Jamjoom Pharmaceuticals Factory's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Jamjoom Pharmaceuticals Factory amounted to 27,231 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Jamjoom Pharmaceuticals Factory's Scope 1 Emissions Over Time

202402 k4 k6 k8 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Jamjoom Pharmaceuticals Factory's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Jamjoom Pharmaceuticals Factory were 7,248 metric tons of CO₂ equivalent (tCO₂e). a

What are Jamjoom Pharmaceuticals Factory's Scope 2 emissions?

In 2024, Jamjoom Pharmaceuticals Factory reported Scope 2 greenhouse gas (GHG) emissions of 19,983 tCO₂e without specifying the calculation method. a

What methodology does Jamjoom Pharmaceuticals Factory use for Scope 2 reporting?

In 2024, Jamjoom Pharmaceuticals Factory reported its Scope 2 emissions using an unspecified methodology. a

Jamjoom Pharmaceuticals Factory's Scope 2 Emissions Over Time

202405 k10 k15 k20 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Jamjoom Pharmaceuticals Factory’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Jamjoom Pharmaceuticals Factory reported Scope 1 greenhouse gas (GHG) emissions of 7,248 tCO₂e and total revenues of USD 351 millions. This translates into an emissions intensity of 20.65 tCO₂e per millions USD. a

Jamjoom Pharmaceuticals Factory's Scope 1 Emissions Intensity Compared to Peers

505005,00020,000200,000Scope 1 Emissions (tCO2e)201005002,00010,000Revenues (Millions of USD)CPSJIOLCPYear: 2025Scope 1: 45,920 tCO2eRevenue: $M 242Scope 1 Intensity: 189.70 tCO2e/$MCanSino BiologicsYear: 2023Scope 1: 3,541 tCO2eRevenue: $M 49Scope 1 Intensity: 72.91 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MCCCR Double-CraneYear: 2023Scope 1: 51,608 tCO2eRevenue: $M 1,438Scope 1 Intensity: 35.88 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MHisamitsu PharmaceuticalYear: 2022Scope 1: 7,862 tCO2eRevenue: $M 1,040Scope 1 Intensity: 7.56 tCO2e/$MSawai Group HoldingsYear: 2023Scope 1: 19,500 tCO2eRevenue: $M 1,229Scope 1 Intensity: 15.87 tCO2e/$MAarti PharmalabsYear: 2024Scope 1: 88,101 tCO2eRevenue: $M 218Scope 1 Intensity: 404.68 tCO2e/$MAlembic PharmaceuticalsYear: 2025Scope 1: 80,278 tCO2eRevenue: $M 765Scope 1 Intensity: 104.88 tCO2e/$MFagronYear: 2023Scope 1: 4,218 tCO2eRevenue: $M 844Scope 1 Intensity: 4.99 tCO2e/$MTong Ren TangYear: 2023Scope 1: 116 tCO2eRevenue: $M 195Scope 1 Intensity: 0.59 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MHUTCHMED (China)Year: 2024Scope 1: 3,083 tCO2eRevenue: $M 4,926Scope 1 Intensity: 0.63 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MEvotecYear: 2024Scope 1: 13,756 tCO2eRevenue: $M 829Scope 1 Intensity: 16.59 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MSSSihuan PharmaceuticalYear: 2023Scope 1: 45,602 tCO2eRevenue: $M 286Scope 1 Intensity: 159.27 tCO2e/$MLotus PharmaceuticalYear: 2024Scope 1: 2,672 tCO2eRevenue: $M 567Scope 1 Intensity: 4.71 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$MChina Medical System HoldingsYear: 2023Scope 1: 1,628 tCO2eRevenue: $M 1,233Scope 1 Intensity: 1.32 tCO2e/$MJamjoom Pharmaceuticals FactoryYear: 2024Scope 1: 7,248 tCO2eRevenue: $M 351Scope 1 Intensity: 20.65 tCO2e/$M

How does Jamjoom Pharmaceuticals Factory's GHG emissions intensity compare to its peers?

In 2024, Jamjoom Pharmaceuticals Factory reported a Scope 1 emissions intensity of 20.65 tCO₂e per millions USD. Compared to the peer group median of 22.52 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Jamjoom Pharmaceuticals Factory rank on GHG emissions intensity within its industry?

In 2024, Jamjoom Pharmaceuticals Factory ranked 13 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Jamjoom Pharmaceuticals Factory is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Jamjoom Pharmaceuticals Factory's GHG Emissions Dataset?
Sign Up